The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
International Histopathology Consensus for Unilateral Primary Aldosteronism
Open accessAbstract
Objective: Develop a consensus for the nomenclature and definition of adrenal histopathologic features in unilateral primary aldosteronism (PA). Context: Unilateral PA is the most common surgically treated form of hypertension. Morphologic examination combined with CYP11B2 (aldosterone synthase) immunostaining reveals diverse histopathologic features of lesions in the resected adrenals. Patients and Methods: Surgically removed adrenals (n = 37) from 90 patients operated from 2015 to 2018 in Munich, Germany, were selected to represent the broad histologic spectrum of unilateral PA. Five pathologists (Group 1 from Germany, Italy, and Japan) evaluated the histopathology of hematoxylin-eosin (HE) and CYP11B2 immunostained sections, and a consensus was established to define the identifiable features. The consensus was subsequently used by 6 additional pathologists (Group 2 from Australia, Brazil, Canada, Japan, United Kingdom, United States) for the assessment of all adrenals with disagreement for histopathologic diagnoses among group 1 pathologists. Results: Consensus was achieved to define histopathologic features associated with PA. Use of CYP11B2 immunostaining resulted in a change of the original HE morphology-driven diagnosis in 5 (14%) of 37 cases. Using the consensus criteria, group 2 pathologists agreed for the evaluation of 11 of the 12 cases of disagreement among group 1 pathologists. Conclusion: The HISTALDO (histopathology of primary aldosteronism) consensus is useful to standardize nomenclature and achieve consistency among pathologists for the histopathologic diagnosis of unilateral PA. CYP11B2 immunohistochemistry should be incorporated into the routine clinical diagnostic workup to localize the likely source of aldosterone production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Self-citationMonticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Self-citationWilliams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 969
Self-citationHundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Nishimoto, K., Tomlins, S. A., Kuick, R., Cani, A. K., Giordano, T. J., Hovelson, D. H., Liu, C.-J., Sanjanwala, A. R., Edwards, M. A., Gomez-Sanchez, C. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505529112 · Cited by 334
Self-citationAdrenocortical zonation in humans under normal and pathological conditions
Nishimoto, K., Nakagawa, K., Li, D., Kosaka, T., Oya, M., Mikami, S., Shibata, H., Itoh, H., Mitani, F., Yamazaki, T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2010 · Cited by 310
Development of monoclonal antibodies against human CYP11B1 and CYP11B2
Gomez-Sanchez, C. E., Qi, X., Velarde-Miranda, C., Plonczynski, M. W., Parker, C. R., Rainey, W., Satoh, F., Maekawa, T., Nakamura, Y., Sasano, H., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.022 · Cited by 283
Self-citationCellular and Genetic Causes of Idiopathic Hyperaldosteronism
Omata, K., Satoh, F., Morimoto, R., Ito, S., Yamazaki, Y., Nakamura, Y., Anand, S. K., Guo, Z., Stowasser, M., Sasano, H., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11086 · Cited by 209
Self-citationAzizan, E. A. B., Lam, B. Y. H., Newhouse, S. J., Zhou, J., Kuc, R. E., Clarke, J., Happerfield, L., Marker, A., Hoffman, G. J., & Brown, M. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2965 · Cited by 190
Self-citationStowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159
Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism
Boulkroun, S., Samson-Couterie, B., Dzib, J. F. G., Lefèbvre, H., Louiset, E., Amar, L., Plouin, P., Lalli, E., Jeunemaître, X., Benecke, A., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158543 · Cited by 155
Monticone, S., Castellano, I., Versace, K., Lucatello, B. G., Veglio, F., Gómez-Sánchez, C. E., Williams, T. A., & Mulatero, P. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.022 · Cited by 147
Self-citationHistopathological classification of cross-sectional image negative hyperaldosteronism
Yamazaki, Y., Nakamura, Y., Omata, K., Ise, K., Tezuka, Y., Ono, Y., Morimoto, R., Nozawa, Y., Gómez-Sánchez, C. E., Tomlins, S. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2986 · Cited by 144
Self-citationRole of KCNJ5 in familial and sporadic primary aldosteronism
Mulatero, P., Monticone, S., Rainey, W. E., Veglio, F., & Williams, T. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.230 · Cited by 133
Self-citationWilliams, T. A., & Reincke, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0990 · Cited by 131
Self-citationThe Biology of Normal Zona Glomerulosa And Aldosterone-Producing Adenoma: Pathological Implications
Seccia, T. M., Caroccia, B., Gómez-Sánchez, E. P., Gómez-Sánchez, C. E., & Rossi, G. P. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00060 · Cited by 120
Nakamura, Y., Maekawa, T., Felizola, S. J. A., Satoh, F., Qi, X., Velarde‐Miranda, C., Plonczynski, M. W., Ise, K., Kikuchi, K., Rainey, W. E., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.002 · Cited by 115
Self-citationHistopathology of the human adrenal cortex
Neville, A. M., & O'Hare, M. J. (1985) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(85)80078-5 · Cited by 108
Primary aldosteronism: hypertension with a genetic basis
Gordon, R. D., Klemm, S. A., Tunny, T. J., & Stowasser, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)93225-c · Cited by 99
Nishimoto, K., Seki, T., Kurihara, I., Yokota, K., Omura, M., Nishikawa, T., Shibata, H., Kosaka, T., Oya, M., Suematsu, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3285 · Cited by 87
Meyer, L. S., Wang, X., Sušnik, E., Burrello, J., Burrello, A., Castellano, I., Eisenhofer, G., Fallo, F., Kline, G. A., Knösel, T., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11465 · Cited by 72
Self-citationDifferent Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma
Fernandes-Rosa, F. L., Giscos-Douriez, I., Amar, L., Gómez-Sánchez, C. E., Méatchi, T., Boulkroun, S., & Zennaro, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05993 · Cited by 70
Primary aldosteronism—some genetic, morphological, and biochemical aspects of subtypes
Gordon, R. D., Stowasser, M., Klemm, S. A., & Tunny, T. J. (1995) · Steroids · doi:10.1016/0039-128x(94)00013-3 · Cited by 55
Disordered CYP11B2 Expression in Primary Aldosteronism
Gómez-Sánchez, C. E., Kuppusamy, M., Reincke, M., & Williams, T. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122238 · Cited by 48
Self-citationOno, Y., Yamazaki, Y., Omata, K., Else, T., Tomlins, S. A., Rhayem, Y., Williams, T. A., Reincke, M., Carling, T., Monticone, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz235 · Cited by 48
Self-citationSun, N., Meyer, L. S., Feuchtinger, A., Kunzke, T., Knösel, T., Reincke, M., Walch, A. K., & Williams, T. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14041 · Cited by 45
Self-citationVolpe, C., Hamberger, B., Höög, A., Mukai, K., Calissendorff, J., Wahrenberg, H., Zedenius, J., & Thorén, M. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12645 · Cited by 41
Yamazaki, Y., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Adachi, Y., Ise, K., Nakamura, Y., Gómez-Sánchez, C. E., Shibahara, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10907 · Cited by 37
Self-citationImmunohistochemistry improves histopathologic diagnosis in primary aldosteronism
Volpe, C., Höög, A., Ogishima, T., Mukai, K., Lu, M. S., Thorén, M. C., & Hamberger, B. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201287 · Cited by 31
Ito, A., Yamazaki, Y., Sasano, H., Matsubara, D., Fukushima, N., Tamba‐Sakaguchi, M., Tabata, K., Ashizawa, K., Takei, A., Koizumi, M., et al. (2017) · Pathology International · doi:10.1111/pin.12521 · Cited by 13
Self-citation
Cited by
Diagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 354
Self-citationOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Self-citation
Metadata
- Authors
- Williams, T. A., Gomez-Sanchez, C. E., Rainey, W. E., Giordano, T. J., Lam, A. K., Marker, A., Mete, O., Yamazaki, Y., Zerbini, M. C. N., Beuschlein, F., Satoh, F., Burrello, J., Schneider, H., Lenders, J. W. M., Mulatero, P., Castellano, I., Knösel, T., Papotti, M., Saeger, W., Sasano, H., & Reincke, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-07-27
- Volume
- 106
- Issue
- 1
- Pages
- 42-54
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3045548795
- Cited by
- 311
- References
- 30
- FWCI
- 20.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.